...
首页> 外文期刊>Molecular pharmaceutics >Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel
【24h】

Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel

机译:使用Flash NanopropipipitipitipitipitipIp从衍生自羧甲基纤维素,聚乙二醇和Cabazitax的两亲性聚合物产生高效稳定的Cellax纳米颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

We report the use of flash nanoprecipitation (FNP) as an efficient and scalable means of producing Cellax nano particles. Cellax polymeric conjugates consisting of carboxymethyl cellulose functionalized with PEG and hydrophobic anticancer drugs, such as cabazitaxel (coined Cellax-CBZ), have been shown to have high potency against several oncology targets, including prostate cancer. FNP, a robust method used to create nanoparticles through rapid mixing, has been used to encapsulate several hydrophobic drugs with block copolymer stabilizers, but has never been used to form nanoparticles from random copolymers, such as Cellax-CBZ. To assess the potential of using FNP to produce Cellax nanoparticles, parameters such as concentration, mixing rate, solvent ratios, and subsequent dilution were tested with a target nanoparticle size range of 60 nm. Under optimized solvent conditions, particles were formed that underwent a subsequent rearrangement to form nanoparticles of 60 nm diameter, independent of Cellax-CBZ polymer concentration. This intraparticle relaxation, without interparticle association, points to a delicate balance of hydrophobic/hydrophilic domains on the polymer backbone. These particles were stable over time, and the random amphiphilicity did not lead to interparticle attractions, which would compromise the stability and corresponding narrow size distribution required for parenteral injection. The amphiphilic nature of these conjugates allows them to be processed into nanoparticles for sustained drug release and improved tumor selectivity. Preferred candidates were evaluated for plasma stability and cytotoxicity against the PC3 prostate cancer cell line in vitro. These parameters are important when assessing nanoparticle safety and for estimating potential efficacy, respectively. The optimal formulations showed plasma stability profiles consistent with long circulating nanoparticles, and cytotoxicity comparable to that of free CBZ. This study demonstrates that FNP is a promising technology for development of Cellax nanoparticles.
机译:我们报告使用闪光纳米沉淀(FNP)作为产生Cellax纳米颗粒的有效和可伸缩的方法。 Cellax聚合物缀合物由用PEG和疏水性抗癌药物官能化的羧甲基纤维素组成,例如Cabazitaxel(Cenrod Cellax-CBZ),对几种肿瘤学靶标具有高效力,包括前列腺癌。 FNP,一种用于通过快速混合产生纳米颗粒的鲁棒方法已经用于用嵌段共聚物稳定剂包封几种疏水药,但从未被用于从无规共聚物中形成纳米颗粒,例如Cellax-CBZ。为了评估使用FNP产生Cellax纳米颗粒的电位,用60nm的靶纳米颗粒尺寸范围测试浓度,混合速率,溶剂比和随后稀释的参数。在优化的溶剂条件下,形成颗粒,其经历了随后的重排,以形成60nm直径的纳米颗粒,与细胞CBZ聚合物浓度无关。这种肿瘤内松弛,没有颗粒间结合,指向聚合物主链上的疏水/亲水结构域的微妙平衡。随着时间的推移,这些颗粒稳定,随机两亲性没有导致颗粒夹层,这会损害肠胃外注射所需的稳定性和相应的窄尺寸分布。这些缀合物的两亲性质允许将它们加工成纳米颗粒以进行持续的药物释放和改善的肿瘤选择性。在体外评估对PC3前列腺癌细胞系的血浆稳定性和细胞毒性评估优选的候选物。当评估纳米粒子安全性和估计潜在疗效时,这些参数非常重要。最佳配方显示了与长循环纳米颗粒一致的等离子体稳定性曲线,以及与游离CBZ的细胞毒性相当。本研究表明,FNP是一种有希望的Cellax纳米颗粒的开发技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号